DPP4 and COVID-19: In addition, outpatients with acute SARS-CoV-2 infection were not enrolled, and this makes the conclusions formally valid only for hospitalized patients with acute COVID-19; however, the significant trend in circulating DPP4 activity reduction associated consistently with more severe COVID-19 outcomes might attenuate these limitations.